Medical Device News Magazine

Peter J Brown Is Appointed President of Reverba

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Reverba, a leading global patient engagement company, today announced the appointment of Peter J. Brown, MBA, as President. He brings more than 20 years of experience in life sciences, healthcare and patient engagement, with a track record of driving growth in highly complex, competitive markets and successfully scaling organizations to support expanding service and product offerings.

“We are delighted to welcome Peter to Reverba. His experience enhances the leadership team and strengthens our ability to transform the way biopharmaceutical companies think and function by incorporating compliant, patient-centered action at the core of their business,” said Cheryl Lubbert, CEO and co-founder of Reverba. “Peter brings the ideal skills we need to accelerate our growth and deliver value for healthcare organizations and patients.”

Peter J Brown joins Reverba at an exciting time, as the company is expanding its proprietary, compliant patient engagement solutions and services to connect biopharma companies with patients to amplify the impact of patient voices.

“I am excited to take on this role at Reverba, a foundational company that helped create the patient engagement space,” said Peter J Brown, President of Reverba. “I see an extraordinary opportunity for Reverba to expand the company’s offerings, built on deep understanding of secure technology solutions that enable meaningful connections with patients.”

Brown joins Reverba from his role as President, Chief Executive Officer and General Manager of Thornberry, provider of hospice and home health software solutions, where he drove market strategy, product development, operations and sales against aggressive financial and operational performance targets, leading two major platform technology initiatives and significant product enhancements. Concurrently, he was Founder and President of Proinligo Consulting, providing support to payers, providers and health systems for digital health services and engagement. He is a Fellow of the Academy for Healthcare Management and holds a Bachelor of Economics from Union College and an MBA in Management from McDonough School of Business, Georgetown University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”